Being able to not only customise treatment plans but provide bioidentical implants to patients is a dream that may not be too far off considering the technology biomaterials platform Dimension Inx has built to create therapeutic products that enable an entirely new approach to tissue regeneration. To learn more about the potential of bioprinting, Dental Tribune International reached out to co-founder and CEO Dr Caralynn Collens about the company’s first product for dental application and the future of custom printed tissues.